None listed
Conditions
Interventions
Intervention1: Lignocaine Spray: 10% Lignocaine spray - 2 puffs (approximately 20 mg) applied over peripheral upper limb vein 5 minutes before IV cannulation.
Control Intervention1: Eutectic Mixture o
Sponsors
Dr Raja Mydeen
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 to 60 years Either gender Requiring IV cannulation as part of routine care Intact skin over selected cannulation site on upper limb Provided written informed consent
Exclusion criteria
Exclusion criteria: Known allergy to local anesthetics History of methemoglobinemia or G6PD deficiency Presence of diabetes mellitus, peripheral vascular disease, or Raynaud s disease Skin infection or ulceration at cannulation site Patients who are critically ill or unconscious Concurrent use of opioids or analgesics that interfere with pain assessment Pediatric patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity assessed using Visual Analogue Scale (VAS) and Local Anesthetic Pain Assessment Questionnaire (LAPAQ)Timepoint: At 0 to 1 minute after IV cannulation | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to onset of local anesthesia (in minutes)Timepoint: At approximately 0 to 5 minutes after application of the drug, prior to IV cannulation;Duration of anesthetic effectTimepoint: Measured from onset of numbness until return of normal sensation assessed at fixed intervals of 15 minutes 30 minutes 45 minutes & 60 minutes after intravenous cannulation;Success rate of first-attempt IV cannulationTimepoint: At 0 minutes (immediately after first IV cannulation attempt);Incidence of adverse effectsTimepoint: At 15 minutes 30 minutes & 60 minutes after drug application;Patient satisfaction & perception of pain relief (using LAPAQ)Timepoint: At 1 to 2 minutes after IV cannulation | — |
Countries
India
Contacts
Public ContactRaja Mydeen
SRM Medical College Hospital and Research Centre
Outcome results
None listed